v1
An open-label study of abarelix in men with symptomatic prostate cancer at risk of treatment with LHRH agonists.
Identifier:nobleid.org/w1/20260515/9D2CD1F8
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/9D2CD1F8)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →